Wells Fargo Reiterates Overweight Rating on Xencor, Inc. (XNCR)

Market Context

Xencor, Inc. operates in the Healthcare sector. The stock currently trades at $29.82 with a market capitalization of $1.2B. The stock has gained 136.5% over the past 52 weeks.

Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Xencor, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Xencor, Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 27, 2026	RBC Capital	Outperform	N/A
Oct 27, 2026	Wedbush	Outperform	N/A
Oct 27, 2026	Wells Fargo	Overweight	N/A
Oct 21, 2026	Wedbush	Outperform	N/A
Sep 28, 2026	Truist Securities	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View XNCR Stock Page